Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2025Cardiology in the YoungOpen Access

Pulmonary artery banding linked to improved 5-year LVEF vs medical therapy alone in pediatric cardiomyopathy.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The suitability of pulmonary artery banding as a treatment strategy for dilated cardiomyopathy and left ventricular non-compaction cardiomyopathy with depressed left ventricular ejection fraction needed to be assessed.

Does pulmonary artery banding combined with medical therapy improve left ventricular ejection fraction in patients with dilated or non-compaction cardiomyopathy with LVEF <35%?

Population

21 patients with dilated cardiomyopathy or left ventricular non-compaction cardiomyopathy and LVEF less than 35%

Comparison

Pulmonary artery banding plus anti-congestion medication vs anti-congestion medication alone

Design

Retrospective study

Follow-up

5 years

Key result

Pulmonary artery banding significantly improved left ventricular ejection fraction over 5 years compared to anti-congestion medication alone in pediatric patients with dilated or non-compaction cardiomyopathy (p=0.0002).

Authors

ASAndrey SemyashkinJNJulia NesterukDGDimitra Giannikopouloui

Discussion

Loading...

Member takes

Overview

Pulmonary artery banding may improve LVEF in select pediatric DCM/LVNC cases; leaves open its role pending larger prospective studies.

Study Design

Type

Cohort (n=21)

Multicenter

No

Structured PICO

Does pulmonary artery banding combined with medical therapy improve left ventricular ejection fraction in patients with dilated or non-compaction cardiomyopathy with LVEF <35%?

P
Population
21 pediatric patients with dilated or left ventricular non-compaction cardiomyopathy and LVEF <35%, treated with pulmonary artery banding or medical therapy alone, followed for 5 years.
I
Intervention
Pulmonary artery banding in combination with anti-congestion medication.
C
Comparator
Anti-congestion medication alone.
O
Outcome
Improvement in left ventricular ejection fraction (LVEF) over a 5-year follow-up period.surrogate

Main Result

p-value: p=0.0002

Pulmonary artery banding combined with anti-congestion medication significantly improves left ventricular ejection fraction and cardiac restoration indices in patients with dilated and non-compaction cardiomyopathy compared to medical therapy alone.

Limitations

  • Retrospective design
  • Small sample size due to the rarity of left ventricular non-compaction cardiomyopathy
  • Relatively short follow-up period of 5 years
  • Small sample size

Cite This Study

Semyashkin et al. (2025) conducted a cohort in Dilated cardiomyopathy or left ventricular non-compaction cardiomyopathy with depressed LVEF (n=21). Pulmonary artery banding vs. Anti-congestion medication alone was evaluated on Left ventricular ejection fraction (LVEF) (p=0.0002). Pulmonary artery banding significantly improved left ventricular ejection fraction over 5 years compared to anti-congestion medication alone in pediatric patients with dilated or non-compaction cardiomyopathy (p=0.0002).

synapsesocial.com/papers/6aa17b654329aea82d72ddb5https://doi.org/10.1017/s1047951125000460
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pulmonary artery banding in pediatric dilated cardiomyopathy: A systematic review and meta-analysis of clinical outcomes and ventricular remodeling2026
  2. 2Pulmonary artery banding in infants and young children with end-stage left ventricular dilated cardiomyopathy-Cohort Study2024 · 1 citations
  3. 3Prophylactic Pulmonary Artery Banding in Pediatric Dilated Cardiomyopathy: An Additional Therapeutic Option2024 · 3 citations
  4. 4Late left ventricular myocardial remodeling after pulmonary artery banding for end-stage dilated cardiomyopathy in infants: an imaging study2023 · 8 citations
  5. 5Pulmonary artery banding for cardiomyopathy in young children: First trial in China2024 · 4 citations